Yan Gong

Yan Gong Ph.D.

Associate Professor

Department: Pharmacotherapy & Translational Research
Business Phone: (352) 273-6297
Business Email: gong@cop.ufl.edu

About Yan Gong

Yan Gong, Ph.D., is an Associate Professor in the Department of Pharmacotherapy and Translational Research at the University of Florida (UF) College of Pharmacy and the UF Center for Pharmacogenomics and Precision Medicine. Dr. Gong received a Ph.D. in Pharmaceutics in 2004 from Department of Pharmaceutics, College of Pharmacy at UF. She also obtained a Master’s Degree in Statistics in 2003 from UF Department of Statistics. Before joining the UF faculty in 2005, she completed one year of post-doctoral fellowship in Cardiovascular Pharmacogenomics at the UF Center for Pharmacogenomics.

Dr. Gong’s research focuses on pharmacogenomics of efficacy and adverse response of antihypertensives medications, and serious adverse drug events such as medication-related osteonecrosis of the jaw (ONJ) and cardiotoxicities related to cancer therapies (Cardio-Oncology). Dr. Gong is a NIH-funded investigator for multiple R01s and U01s. Dr. Gong was also funded by the Clinical and Translational Science Institute (CTSI) to 1). develop a computable phenotype for cancer drug induced cardiotoxicity in the Electronic Health Records in order to evaluate this clinically significant adverse event in the real-world settings of OneFlorida Clinical Research Consortium; 2). To identify pharmacogenomic, medical imaging biomarkers and clinical factors associated with cardiotoxicity related to cancer therapies through a multimodal approach using existing data from the UK Biobank. Dr. Gong is also leading the newly established Cardio-Oncology Research Interest Group in the Cardiovascular Collaborative Research Group of the National Patient-centered Clinical Research Network (PCORnet). Dr. Gong has authored over 140 peer-reviewed publications.

https://www.ncbi.nlm.nih.gov/myncbi/yan.gong.1/bibliography/public/

In addition to research, Dr. Gong has been involved in teaching multiple graduate level and professional level courses at the UF College of Pharmacy and College of Medicine. She is currently the course coordinator for Pharmacogenomics (PHA6449), a required graduate level course for the Department of Pharmacotherapy and Translational Research at the UF College of Pharmacy.

Publications

2015 Cancer Treatment Reviews
2014 Journal of the American Society of Hypertension

Grants

September 2018ACTIVE
Pharmacokinetics of Anti-tuberculosis and Antiretroviral Drugs in Children
NATL INST OF HLTH NICHD · Project Manager
August 2018ACTIVE
Carboxylesterase 1 Genetic Variation and Methylphenidate in ADHD
NATL INST OF HLTH NICHD ·
April 2017 – June 2020
OoR CTSI Institutional Matching Support
UF DIV OF SPONSORED RES MATCHING FUNDS · Project Manager
April 2017ACTIVE
HSC COM Matching Commitment
UNIV OF FLORIDA · Project Manager
July 2016ACTIVE
A stem cell tactic to promote personalized medicine
NATL INST OF HLTH NIGMS · Project Manager
June 2016 – August 2018
Pharmacokinetics of Anti-tuberculosis and Antiretroviral Drugs in Children
NATL INST OF HLTH NICHD ·
October 2015 – March 2019
OneFlorida Clinical Research Consortium Phase II
PATIENT-CENTERED OUTCOMES RES INST ·
April 2015ACTIVE
Clinical and Translational Science Institute (CTSI)
UF DIV OF SPONSORED RES MATCHING FUNDS · Project Manager
June 2014ACTIVE
Mechanisms and Treatment Response of Aggressive Periodontitis in Children
NATL INST OF HLTH NIDCR · Project Manager

Education

2004
Ph.D.
University of Florida
2003
M.S.
University of Florida
1999
M.S.
West China University of Medical Sciences

Contact Details

Phones:
Business:
(352) 273-6297
Emails:
Business:
gong@cop.ufl.edu
Addresses:
Mailing:
PO BOX 100486
1600 SW ARCHER ROAD
UNIVERSITY OF FLORIDA HEALTH SCIENCE CENTER
GAINESVILLE, FL 326100486
Physical:
1345 CENTER DR
GAINESVILLE, FL 32610